<code id='9D33689919'></code><style id='9D33689919'></style>
    • <acronym id='9D33689919'></acronym>
      <center id='9D33689919'><center id='9D33689919'><tfoot id='9D33689919'></tfoot></center><abbr id='9D33689919'><dir id='9D33689919'><tfoot id='9D33689919'></tfoot><noframes id='9D33689919'>

    • <optgroup id='9D33689919'><strike id='9D33689919'><sup id='9D33689919'></sup></strike><code id='9D33689919'></code></optgroup>
        1. <b id='9D33689919'><label id='9D33689919'><select id='9D33689919'><dt id='9D33689919'><span id='9D33689919'></span></dt></select></label></b><u id='9D33689919'></u>
          <i id='9D33689919'><strike id='9D33689919'><tt id='9D33689919'><pre id='9D33689919'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:893
          The logo of Department of Justice on a podium — coverage from STAT
          BRENDAN SMIALOWSKI/AFP via Getty Images

          A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

          Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

          advertisement

          STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Prior authorization reform is both possible and imperative
          Prior authorization reform is both possible and imperative

          AdobeImaginethisscene:Youareacancerpatientalreadynavigatingfearanduncertaintyaroundyourtreatment,whe

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          To bolster infectious disease surveillance, genomics powerhouses team up

          TuliodeOliveiraleadsSouthAfrica’sCentreforEpidemicResponseandInnovation.CourtesyCERI@SULONDON—Twores